Form D · Biotechnology
DNATRIX INC
Houston, TX · CIK 0001446505
Offering snapshot reported Sep 25, 2018 · SEC filing
- Reported sold
- $15.5M Offering amount: $41.2M
- Investors reported
- 40 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 12, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 25, 2018 | Initial | $15,529,295 | No comparison | 40 | SEC filing |
| Oct 17, 2014 | Initial | $12,781,419 | No comparison | 31 | SEC filing |
| Nov 7, 2013 | Initial | $1,543,905 | No comparison | 13 | SEC filing |
| Aug 3, 2012 | Initial | $885,620 | No comparison | 10 | SEC filing |
| Sep 24, 2008 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-322084
Source: Form D, filed Sep 25, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Isaac Cheng | Director |
| Imre Kovesdi | Director, Executive |
| Reenie Mc Carthy | Director |
| Francis Patrick Mc Cormick | Director |
| Brian Mooney | Executive |
| Drew Pardoll | Director |
| Frank Tufaro | Director, Executive |
| Daniel Watkins | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2450 Holcombe Blvd. Suite X+200
Houston, TX, 77021
Houston, TX, 77021